D-0914-2018 Class II Terminated
FDA drug recall D-0914-2018 was initiated by Mckesson Packaging Services on Feb 26, 2018 and is designated Class II. Reason for recall: Failed Stability Specifications The recall status is terminated (terminated Sep 15, 2020). Affected quantity: 17,192 cartons (1,719,200 tablets).
Recall details
- Product Type
- Drugs
- Report Date
- Mar 14, 2018
- Initiation Date
- Feb 26, 2018
- Termination Date
- Sep 15, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 17,192 cartons (1,719,200 tablets)
Product description
RANITIDINE Tablets, USP 150 mg UD 100 tablets (10x10), RX Only, Manufactured by: Amneal Pharmaceuticals, Hauppauge, NY 11788, NDC 63739-489-10
Reason for recall
Failed Stability Specifications
Distribution pattern
Nationwide
Code information
Lots: 0113064 Exp. 03/2018, 0114628 Exp. 08/2018, 0115189 Exp. 08/2018, 0115462 Exp. 09/2018
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0914-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026